Sackler family, Purdue Pharma boost multistate opioid settlement to $7.4B in new agreement
In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s Sup | The billionaire family behind former OxyContin maker Purdue Pharma was denied a bankruptcy protection deal in a high-profile Supreme Court ruling last summer.
Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running ...
The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.
Sackler family, who owned pharmaceutical company Purdue Pharma, will no longer be in control of the company or permitted to sell opioids if the new settlement plan is approved ...
Pennsylvania expects to receive $212 million over 15 years as part of a multi-state settlement with the Sackler family, who ...
4hon MSN
Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...
Hosted on MSN18h
New $7.4B Sackler Deal Has Unusual ConditionA new settlement has been reached on lawsuits against Oxycontin maker Purdue Pharma and the Sackler family that owns it, seven months after the Supreme Court rejected a $6 billion deal. The $7.4 ...
The agreement, announced Thursday, would require the Sackler family to pay $6.5 billion over the next 15 years and an additional nearly $900 million from Purdue Pharma following its emergence from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback